News & Updates
Showing Cardiology articles
Showing
Show Multimedia Only

ASCVD affects 1 in 6 adults with β-thalassaemia; etopivat shows promise
04 Aug 2026
byElvira Manzano
Atherosclerotic cardiovascular disease (ASCVD) affects a substantial proportion of adults with β-thalassaemia. It appears to be driven by conventional CV risk factors rather than disease-specific features, according to research presented at EHA2026.
ASCVD affects 1 in 6 adults with β-thalassaemia; etopivat shows promise
04 Aug 2026
Which anti-obesity drug is safest, most effective?
27 Jul 2026
byStephen Padilla
Among available drugs for obesity, tirzepatide and cagrilintide-semaglutide (CagriSema) yield the largest decrease in body weight, regardless of diabetes status, suggest the results of a systematic review and network meta-analysis.







